Changes in taste among pediatric patients with cancer and hematopoietic stem cell transplantation recipients.


Journal

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257

Informations de publication

Date de publication:
Nov 2019
Historique:
accepted: 26 06 2019
pubmed: 6 7 2019
medline: 16 1 2020
entrez: 6 7 2019
Statut: ppublish

Résumé

Changes in taste is a common bothersome symptom in children receiving cancer treatments. However, little is known about how pediatric cancer patients experience this symptom. The objective was to describe how children receiving cancer treatments experience taste alterations and the approaches they use to address the issue. In this qualitative study, we included English-speaking children 4-18 years of age with cancer or hematopoietic stem cell transplantation recipients who were actively receiving cancer treatment or who had completed therapy. Using a semi-structured questionnaire, we asked questions about the experience of altered taste sensation. We asked about its characteristics, impacts and identified coping strategies. We included 50 children. Children experienced changes in taste in a heterogeneous fashion although commonly described food as tasting "different", "not right" or "funny". While change in food preferences due to taste alterations was common, specific choices varied. Many found changes started with treatment initiation or mid-way through treatment, and some found that symptoms persisted up to 9 months following treatment completion. Actions taken to address taste changes were sucking on candy, brushing teeth and modifying food choices. The experience of changes in taste was common yet highly variable in its presentation and resultant changes in food preferences. Taste changes did not always resolve soon after treatment completion. Future research should identify ways to manage this symptom in pediatric cancer patients.

Identifiants

pubmed: 31273626
doi: 10.1007/s11136-019-02242-5
pii: 10.1007/s11136-019-02242-5
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2941-2949

Références

Clin Nutr. 2017 Dec;36(6):1642-1648
pubmed: 27836309
Cancer Med. 2018 May;7(5):1750-1755
pubmed: 29573197
Cancer. 1990 Oct 1;66(7):1649-53
pubmed: 2208017
J Pain Symptom Manage. 2007 Feb;33(2):156-65
pubmed: 17280921
Soc Sci Med. 1990;30(11):1161-72
pubmed: 2360052
Acta Oncol. 2014 Oct;53(10):1405-12
pubmed: 24702121
Cancer Nurs. 2009 Jan-Feb;32(1):45-54
pubmed: 19104201
Nutr J. 2010 Mar 24;9:15
pubmed: 20334666
Int J Radiat Oncol Biol Phys. 1978 Jul-Aug;4(7-8):663-70
pubmed: 711538
Support Care Cancer. 2013 Feb;21(2):549-55
pubmed: 22864536
Bone Marrow Transplant. 2002 Dec;30(11):785-92
pubmed: 12439702
J Clin Oncol. 2009 Apr 10;27(11):1899-905
pubmed: 19289621
BMC Cancer. 2019 Jan 8;19(1):32
pubmed: 30621617
Support Care Cancer. 2012 Nov;20(11):2765-74
pubmed: 22350644
J Oral Pathol Med. 2013 Jan;42(1):106-12
pubmed: 22862149
Cancer Treat Rev. 2014 Oct;40(9):1106-17
pubmed: 25064135
J Pain Symptom Manage. 2007 Oct;34(4):403-12
pubmed: 17616338
Support Care Cancer. 2019 Jun;27(6):2247-2254
pubmed: 30324284
JPEN J Parenter Enteral Nutr. 1982 Jul-Aug;6(4):287-90
pubmed: 6752449
J Pain Symptom Manage. 2012 Dec;44(6):880-95
pubmed: 22921177
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
J Natl Cancer Inst. 2018 Jun 1;110(6):661-668
pubmed: 29272441
Support Care Cancer. 2006 Apr;14(4):369-78
pubmed: 16633841
Health Promot Chronic Dis Prev Can. 2017 Nov;37(11):393
pubmed: 29119777

Auteurs

Robyn Loves (R)

Program in Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, 686 Bay Street, Toronto, ON, M5G 0A4, Canada.

Erin Plenert (E)

Program in Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, 686 Bay Street, Toronto, ON, M5G 0A4, Canada.

Vivian Tomlinson (V)

Program in Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, 686 Bay Street, Toronto, ON, M5G 0A4, Canada.

Sasha Palmert (S)

Program in Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, 686 Bay Street, Toronto, ON, M5G 0A4, Canada.

Gloria Green (G)

Division of Clinical Dietetics, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.
Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.

Tal Schechter (T)

Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.

Deborah Tomlinson (D)

Program in Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, 686 Bay Street, Toronto, ON, M5G 0A4, Canada.

Emily Vettese (E)

Program in Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, 686 Bay Street, Toronto, ON, M5G 0A4, Canada.

Sue Zupanec (S)

Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.

L Lee Dupuis (LL)

Program in Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, 686 Bay Street, Toronto, ON, M5G 0A4, Canada.
Department of Pharmacy, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.

Lillian Sung (L)

Program in Child Health Evaluative Sciences, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, 686 Bay Street, Toronto, ON, M5G 0A4, Canada. lillian.sung@sickkids.ca.
Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. lillian.sung@sickkids.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH